{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,10]],"date-time":"2026-09-10T06:27:28Z","timestamp":1789021648437,"version":"build-2803163510"},"reference-count":15,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2015,4,2]],"date-time":"2015-04-02T00:00:00Z","timestamp":1427932800000},"content-version":"unspecified","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Med Case Reports"],"published-print":{"date-parts":[[2015,12]]},"DOI":"10.1186\/s13256-015-0547-2","type":"journal-article","created":{"date-parts":[[2015,4,1]],"date-time":"2015-04-01T18:21:19Z","timestamp":1427912479000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":23,"title":["Clozapine toxicity due to a multiple drug interaction: a case report"],"prefix":"10.1186","volume":"9","author":[{"given":"Giovanna","family":"Cadeddu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Arianna","family":"Deidda","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria Erminia","family":"Stochino","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nicola","family":"Velluti","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Caterina","family":"Burrai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maria","family":"Del Zompo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2015,4,2]]},"reference":[{"key":"547_CR1","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1056\/NEJM199103143241107","volume":"324","author":"RJ Baldessarini","year":"1991","unstructured":"Baldessarini RJ, Frankenburg FR. Clozapine. A novel antipsychotic agent. N Engl J Med. 1991;324:746\u201354.","journal-title":"N Engl J Med"},{"key":"547_CR2","doi-asserted-by":"publisher","first-page":"183","DOI":"10.1159\/000096666","volume":"108","author":"S Rathore","year":"2007","unstructured":"Rathore S, Masani ND, Callaghan PO. Clozapine-induced effuso-constrictive pericarditis. Case report and review of the literature. Cardiology. 2007;108:183\u20135.","journal-title":"Cardiology."},{"key":"547_CR3","doi-asserted-by":"publisher","first-page":"91","DOI":"10.1111\/j.1365-2710.2004.00616_1.x","volume":"30","author":"PM Wehmeier","year":"2005","unstructured":"Wehmeier PM, Heiser P, Remschmidt H. Myocarditis, pericarditis and cardiomyopathy in patients treated with clozapine. J Clin Pharm Ther. 2005;30:91\u20136.","journal-title":"J Clin Pharm Ther."},{"key":"547_CR4","doi-asserted-by":"publisher","first-page":"453","DOI":"10.1016\/S0924-977X(99)00033-4","volume":"9","author":"B Buur-Rasmussen","year":"1999","unstructured":"Buur-Rasmussen B, Brosen K. Cytochrome P450 and therapeutic drug monitoring with respect to clozapine. Eur Neuropsychopharmacol. 1999;9:453\u20139.","journal-title":"Eur Neuropsychopharmacol."},{"key":"547_CR5","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1046\/j.1365-2125.1997.t01-1-00605.x","volume":"44","author":"B Eiermann","year":"1997","unstructured":"Eiermann B, Engel G, Johansson I, Zanger UM, Bertilsson L. The involvement of CYP1A2 and CYP3A4 in the metabolism of clozapine. Br J Clin Pharmacol. 1997;44:439\u201346.","journal-title":"Br J Clin Pharmacol."},{"key":"547_CR6","doi-asserted-by":"publisher","first-page":"823","DOI":"10.1177\/00912700122010717","volume":"41","author":"OV Olesen","year":"2001","unstructured":"Olesen OV, Linnet K. Contribution of five human cytochrome P450 isoforms to the N-demethylation of clozapine in vitro at low and high concentration. J Clin Pharmacol. 2001;41:823\u201332.","journal-title":"J Clin Pharmacol."},{"key":"547_CR7","doi-asserted-by":"publisher","first-page":"577","DOI":"10.1111\/j.1472-8206.1999.tb00364.x","volume":"13","author":"H Bun","year":"1999","unstructured":"Bun H, Disdier B, Aubert C, Catalin J. Interspecies variability and drug interactions of clozapine metabolism by microsomes. Fundam Clin Pharmacol. 1999;13:577\u20138.","journal-title":"Fundam Clin Pharmacol."},{"key":"547_CR8","doi-asserted-by":"publisher","first-page":"1805","DOI":"10.1248\/bpb.28.1805","volume":"28","author":"T Niwa","year":"2005","unstructured":"Niwa T, Shiraga T, Takagi A. Effect of antifungal drugs on cytochrome P450 (CYP) 2C9, CYP2C19, and CYP3A4 activities in human liver microsomes. Biol Pharm Bull. 2005;28:1805\u20138.","journal-title":"Biol Pharm Bull."},{"key":"547_CR9","doi-asserted-by":"publisher","first-page":"221","DOI":"10.1111\/j.1365-2710.2011.01271.x","volume":"37","author":"W Mahatthanatrakul","year":"2012","unstructured":"Mahatthanatrakul W, Sriwiriyajan S, Ridtitid W, Boonleang J, Wongnawa M, Rujimamahasan N, et al. Effect of cytochrome P450 3A4 inhibitor ketoconazole on risperidone pharmacokinetics in healthy volunteers. J Clin Pharm Ther. 2012;37:221\u20135.","journal-title":"J Clin Pharm Ther."},{"key":"547_CR10","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1097\/00004714-200212000-00013","volume":"22","author":"V Gabbay","year":"2002","unstructured":"Gabbay V, O\u2019Dowd MA, Mamamtavrishvili M, Asnis GM. Clozapine and oral contraceptives: a possible drug interaction. J Clin Psychopharmacol. 2002;22:621\u20132.","journal-title":"J Clin Psychopharmacol."},{"key":"547_CR11","doi-asserted-by":"publisher","first-page":"234","DOI":"10.1177\/0269881103017002014","volume":"17","author":"C Greenwood-Smith","year":"2003","unstructured":"Greenwood-Smith C, Lubman DI, Castle DJ. Serum clozapine levels: a review of their clinical utility. J Psychopharmacol. 2003;17:234\u20138.","journal-title":"J Psychopharmacol."},{"key":"547_CR12","doi-asserted-by":"publisher","first-page":"239","DOI":"10.1038\/clpt.1981.154","volume":"30","author":"CA Naranjo","year":"1981","unstructured":"Naranjo CA, Busto U, Sellers EM, Sandor P, Ruiz I, Roberts EA, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239\u201345.","journal-title":"Clin Pharmacol Ther."},{"key":"547_CR13","doi-asserted-by":"publisher","first-page":"674","DOI":"10.1345\/aph.1H423","volume":"41","author":"JR Horn","year":"2007","unstructured":"Horn JR, Hansten PD, Chan LN. Proposal for a new tool to evaluate drug interaction cases. Ann Pharmacother. 2007;41:674\u201380.","journal-title":"Ann Pharmacother."},{"key":"547_CR14","doi-asserted-by":"publisher","first-page":"1667","DOI":"10.1124\/dmd.109.026997","volume":"37","author":"SY Chang","year":"2009","unstructured":"Chang SY, Chen C, Yang Z, Rodrigues AD. Further assessment of 17alpha-ethinyl estradiol as an inhibitor of different human cytochrome P450 forms in vitro. Drug Metab Dispos. 2009;37:1667\u201375.","journal-title":"Drug Metab Dispos."},{"key":"547_CR15","doi-asserted-by":"publisher","first-page":"157","DOI":"10.1111\/j.1742-7843.2008.00252.x","volume":"103","author":"MJ Karjalainen","year":"2008","unstructured":"Karjalainen MJ, Neuvonen PJ, Backman JT. In vitro inhibition of CYP1A2 by model inhibitors, anti-inflammatory analgesics and female sex steroids: predictability of in vivo interactions. Basic Clin Pharmacol Toxicol. 2008;103:157\u201365.","journal-title":"Basic Clin Pharmacol Toxicol."}],"container-title":["Journal of Medical Case Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0547-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1186\/s13256-015-0547-2\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0547-2.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1186\/s13256-015-0547-2","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2021,9,2]],"date-time":"2021-09-02T10:26:41Z","timestamp":1630578401000},"score":1,"resource":{"primary":{"URL":"https:\/\/jmedicalcasereports.biomedcentral.com\/articles\/10.1186\/s13256-015-0547-2"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,4,2]]},"references-count":15,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2015,12]]}},"alternative-id":["547"],"URL":"https:\/\/doi.org\/10.1186\/s13256-015-0547-2","relation":{},"ISSN":["1752-1947"],"issn-type":[{"value":"1752-1947","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,4,2]]},"assertion":[{"value":"31 July 2014","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"18 February 2015","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2015","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"77"}}